Allianz Asset Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-39,629
| Closed | -$466K | – | 2336 |
|
|
2019
Q2 | $466K | Sell |
39,629
-2,452
| -6% | -$28.8K | ﹤0.01% | 1947 |
|
|
2019
Q1 | $575K | Buy |
42,081
+4,506
| +12% | +$61.6K | ﹤0.01% | 1915 |
|
|
2018
Q4 | $384K | Buy |
37,575
+15,465
| +70% | +$158K | ﹤0.01% | 1914 |
|
|
2018
Q3 | $369K | Hold |
22,110
| – | – | ﹤0.01% | 1961 |
|
|
2018
Q2 | $349K | Hold |
22,110
| – | – | ﹤0.01% | 1931 |
|
|
2018
Q1 | $281K | Hold |
22,110
| – | – | ﹤0.01% | 1980 |
|
|
2017
Q4 | $253K | Hold |
22,110
| – | – | ﹤0.01% | 2036 |
|
|
2017
Q3 | $271K | Buy |
22,110
+1,300
| +6% | +$15.9K | ﹤0.01% | 1990 |
|
|
2017
Q2 | $250K | Sell |
20,810
-290
| -1% | -$3.48K | ﹤0.01% | 1998 |
|
|
2017
Q1 | $441K | Sell |
21,100
-13,061
| -38% | -$273K | ﹤0.01% | 1889 |
|
|
2016
Q4 | $711K | Sell |
34,161
-36,537
| -52% | -$760K | ﹤0.01% | 1770 |
|
|
2016
Q3 | $2.29M | Buy |
70,698
+10,531
| +18% | +$341K | ﹤0.01% | 1448 |
|
|
2016
Q2 | $1.5M | Buy |
60,167
+40,055
| +199% | +$1,000K | ﹤0.01% | 1527 |
|
|
2016
Q1 | $492K | Buy |
20,112
+1,042
| +5% | +$25.5K | ﹤0.01% | 1718 |
|
|
2015
Q4 | $644K | Hold |
19,070
| – | – | ﹤0.01% | 1663 |
|
|
2015
Q3 | $625K | Sell |
19,070
-3,500
| -16% | -$115K | ﹤0.01% | 1609 |
|
|
2015
Q2 | $1.2M | Buy |
+22,570
| New | +$1.2M | ﹤0.01% | 1489 |
|